Quick Takeaways
- RTW INVESTMENTS, LP filed SCHEDULE 13G for Rapt Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT).
- Disclosed ownership: 8.9%.
- Date of event: 31 Mar 2025.
RTW INVESTMENTS, LP - 31 Mar 2025 SCHEDULE 13G Report for Rapt Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT)
- Filing Manager
- RTW INVESTMENTS, LP
- Reporting Manager
- RTW Investments, LP
- Symbol
- RAPT
- Shares outstanding
- 132,179,775 shares
- Disclosed Ownership
- 11,764,000 shares
- Ownership
- 8.9%
- Form type
- SCHEDULE 13G
- Filing time
- 15 May 2025, 08:00:10 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"RTW INVESTMENTS, LP disclosed 8.9% ownership in Rapt Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 May 2025, 08:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RTW Investments, LP | 8.9% | 11,764,000 | 0 | 11,764,000 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D., Managing Partner | |
| Roderick Wong, M.D. | 8.9% | 11,764,000 | 0 | 11,764,000 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D. |